CAFARO, ALESSIA
CAFARO, ALESSIA
100008 - Dipartimento di medicina sperimentale
A LC-MS/MS METHOD FOR THE QUANTIFICATION OF CENOBAMATE USING VOLUMETRIC ADSORPTIVE MICROSAMPLING (VAMS)
2023-01-01 Pigliasco, F.; Cafaro, A.; Barco, S.; Riva, A.; Striano, P.; Micalizzi, E.; Villani, F.; Cangemi, G.
A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients
2024-01-01 Cafaro, Alessia; Baiardi, Giammarco; Pigliasco, Federica; Barco, Sebastiano; Mattioli, Francesca; Volpi, Stefano; Caorsi, Roberta; Gattorno, Marco; Cangemi, Giuliana
A NOVEL LC–MS/MS METHOD FOR THERAPEUTIC DRUG MONITORING OF APIXABAN IN PLASMA AND DRIED PLASMA SPOT: A POTENTIAL TOOL FOR THE OPTIMIZATION OF DIRECT ANTICOAGULANT DRUGS IN SPECIAL POPULATIONS
2023-01-01 Cafaro, A.; Baiardi, G.; Stella, M.; Pigliasco, F.; Barco, S.; Mattioli, F.; Cangemi, G.
A novel LC–MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot
2021-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Penco, F.; Schena, F.; Caorsi, R.; Volpi, S.; Tripodi, G.; Gattorno, M.; Cangemi, G.
Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity
2022-01-01 Signa, Sara; Bertoni, Arinna; Penco, Federica; Caorsi, Roberta; Cafaro, Alessia; Cangemi, Giuliana; Volpi, Stefano; Gattorno, Marco; Schena, Francesca
Altered plasma levels of apixaban in major gastrointestinal tract surgery: A case report and review of the literature
2023-01-01 Baiardi, Giammarco; Cafaro, Alessia; Stella, Manuela; CAMERAN CAVIGLIA, Michela; Poeta, MARIA GABRIELLA; Cangemi, Giuliana; Mattioli, Francesca
Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy
2021-01-01 Palermiti, Alice; Cafaro, Alessia; Barco, Sebastiano; Bucchioni, Paolo; Franceschini, Paolo; Cusato, Jessica; De Nicolò, Amedeo; Manca, Alessandra; Delia De Vivo, Elisa; Russo, Eleonora; Cecchi, Francesco; Pigliasco, Federica; Lillo, Flavia; Tripodi, Gino; D’Avolio, Antonio; Cangemi, Giuliana
Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
2022-01-01 Pigliasco, F.; Malaca, S.; Lo Faro, A. F.; Tini, A.; Cangemi, G.; Cafaro, A.; Barco, S.; Riva, A.; Pisati, A.; Amadori, E.; Striano, P.; Tagliabracci, A.; Huestis, M. A.; Busardo, F. P.
Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
2023-01-01 Cafaro, Alessia; Pigliasco, Federica; Baiardi, Giammarco; Barco, Sebastiano; Stella, Manuela; Bandettini, Roberto; Mattioli, Francesca; Faraci, Maura; Cangemi, Giuliana
Dose optimization and target attainment of vancomycin in children
2024-01-01 Cafaro, Alessia; Stella, Manuela; Mesini, Alessio; Castagnola, Elio; Cangemi, Giuliana; Mattioli, Francesca; Baiardi, Giammarco
Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method
2024-01-01 Cafaro, A; Stella, M; Baiardi, G; Barco, S; Pigliasco, F; Bandettini, R; Nanni, L; Mattioli, F; Cangemi, G
Indications for the harmonization of the therapeutic intervals of antibacterial drugs|Indicazioni per l'armonizzazione degli intervalli terapeutici dei farmaci antibatterici
2022-01-01 Cangemi, G.; Barbagallo, L.; Cafaro, A.; Pigliasco, F.; Maria, Goffredo; Di Paolo, A.
Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy
2024-01-01 Pigliasco, F; Cafaro, A; Barco, S; Stella, M; Mattioli, F; Riva, A; Mancardi, Mm; Lattanzi, S; Bandettini, R; Striano, P; Cangemi, G
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method”
2022-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Stella, M.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Cangemi, G.; Mattioli, F.
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD
2023-01-01 Pigliasco, F.; Cafaro, A.; Stella, M.; Baiardi, G.; Barco, S.; Pedemonte, N.; D'Orsi, C.; Cresta, F.; Casciaro, R.; Castellani, C.; Calevo, M. G.; Cangemi, G.; Mattioli, F.
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
2023-01-01 Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana
Therapeutic drug monitoring of medical cannabis in pediatrics: The experience of Giannina Gaslini Institute|Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini
2023-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Riva, A.; Striano, P.; Manfredini, L.; Barabino, P.; Mattioli, F.; Pichini, S.; Busardo, F. P.; Cangemi, G.
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica
2023-01-01 Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A.
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations
2021-01-01 Malaca, S.; Gottardi, M.; Pigliasco, F.; Barco, S.; Cafaro, A.; Amadori, E.; Riva, A.; Marcenaro, M.; Striano, P.; Cangemi, G.; Pacifici, R.; Pichini, S.; Busardo, F. P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A LC-MS/MS METHOD FOR THE QUANTIFICATION OF CENOBAMATE USING VOLUMETRIC ADSORPTIVE MICROSAMPLING (VAMS) | 1-gen-2023 | Pigliasco, F.; Cafaro, A.; Barco, S.; Riva, A.; Striano, P.; Micalizzi, E.; Villani, F.; Cangemi, G. | |
| A Novel LC-MS/MS Method for Therapeutic Drug Monitoring of Baricitinib in Plasma of Pediatric Patients | 1-gen-2024 | Cafaro, Alessia; Baiardi, Giammarco; Pigliasco, Federica; Barco, Sebastiano; Mattioli, Francesca; Volpi, Stefano; Caorsi, Roberta; Gattorno, Marco; Cangemi, Giuliana | |
| A NOVEL LC–MS/MS METHOD FOR THERAPEUTIC DRUG MONITORING OF APIXABAN IN PLASMA AND DRIED PLASMA SPOT: A POTENTIAL TOOL FOR THE OPTIMIZATION OF DIRECT ANTICOAGULANT DRUGS IN SPECIAL POPULATIONS | 1-gen-2023 | Cafaro, A.; Baiardi, G.; Stella, M.; Pigliasco, F.; Barco, S.; Mattioli, F.; Cangemi, G. | |
| A novel LC–MS/MS-based method for the diagnosis of ADA2 deficiency from dried plasma spot | 1-gen-2021 | Cafaro, A.; Pigliasco, F.; Barco, S.; Penco, F.; Schena, F.; Caorsi, R.; Volpi, S.; Tripodi, G.; Gattorno, M.; Cangemi, G. | |
| Adenosine Deaminase 2 Deficiency (DADA2): A Crosstalk Between Innate and Adaptive Immunity | 1-gen-2022 | Signa, Sara; Bertoni, Arinna; Penco, Federica; Caorsi, Roberta; Cafaro, Alessia; Cangemi, Giuliana; Volpi, Stefano; Gattorno, Marco; Schena, Francesca | |
| Altered plasma levels of apixaban in major gastrointestinal tract surgery: A case report and review of the literature | 1-gen-2023 | Baiardi, Giammarco; Cafaro, Alessia; Stella, Manuela; CAMERAN CAVIGLIA, Michela; Poeta, MARIA GABRIELLA; Cangemi, Giuliana; Mattioli, Francesca | |
| Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy | 1-gen-2021 | Palermiti, Alice; Cafaro, Alessia; Barco, Sebastiano; Bucchioni, Paolo; Franceschini, Paolo; Cusato, Jessica; De Nicolò, Amedeo; Manca, Alessandra; Delia De Vivo, Elisa; Russo, Eleonora; Cecchi, Francesco; Pigliasco, Federica; Lillo, Flavia; Tripodi, Gino; D’Avolio, Antonio; Cangemi, Giuliana | |
| Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients | 1-gen-2022 | Pigliasco, F.; Malaca, S.; Lo Faro, A. F.; Tini, A.; Cangemi, G.; Cafaro, A.; Barco, S.; Riva, A.; Pisati, A.; Amadori, E.; Striano, P.; Tagliabracci, A.; Huestis, M. A.; Busardo, F. P. | |
| Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children | 1-gen-2023 | Cafaro, Alessia; Pigliasco, Federica; Baiardi, Giammarco; Barco, Sebastiano; Stella, Manuela; Bandettini, Roberto; Mattioli, Francesca; Faraci, Maura; Cangemi, Giuliana | |
| Dose optimization and target attainment of vancomycin in children | 1-gen-2024 | Cafaro, Alessia; Stella, Manuela; Mesini, Alessio; Castagnola, Elio; Cangemi, Giuliana; Mattioli, Francesca; Baiardi, Giammarco | |
| Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method | 1-gen-2024 | Cafaro, A; Stella, M; Baiardi, G; Barco, S; Pigliasco, F; Bandettini, R; Nanni, L; Mattioli, F; Cangemi, G | |
| Indications for the harmonization of the therapeutic intervals of antibacterial drugs|Indicazioni per l'armonizzazione degli intervalli terapeutici dei farmaci antibatterici | 1-gen-2022 | Cangemi, G.; Barbagallo, L.; Cafaro, A.; Pigliasco, F.; Maria, Goffredo; Di Paolo, A. | |
| Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy | 1-gen-2024 | Pigliasco, F; Cafaro, A; Barco, S; Stella, M; Mattioli, F; Riva, A; Mancardi, Mm; Lattanzi, S; Bandettini, R; Striano, P; Cangemi, G | |
| Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” | 1-gen-2022 | Cafaro, A.; Pigliasco, F.; Barco, S.; Stella, M.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Cangemi, G.; Mattioli, F. | |
| QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD | 1-gen-2023 | Pigliasco, F.; Cafaro, A.; Stella, M.; Baiardi, G.; Barco, S.; Pedemonte, N.; D'Orsi, C.; Cresta, F.; Casciaro, R.; Castellani, C.; Calevo, M. G.; Cangemi, G.; Mattioli, F. | |
| Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method | 1-gen-2023 | Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana | |
| Therapeutic drug monitoring of medical cannabis in pediatrics: The experience of Giannina Gaslini Institute|Il monitoraggio terapeutico della Cannabis medica nei pazienti pediatrici: l’esperienza dell’Istituto Giannina Gaslini | 1-gen-2023 | Cafaro, A.; Pigliasco, F.; Barco, S.; Riva, A.; Striano, P.; Manfredini, L.; Barabino, P.; Mattioli, F.; Pichini, S.; Busardo, F. P.; Cangemi, G. | |
| Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica | 1-gen-2023 | Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A. | |
| UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations | 1-gen-2021 | Malaca, S.; Gottardi, M.; Pigliasco, F.; Barco, S.; Cafaro, A.; Amadori, E.; Riva, A.; Marcenaro, M.; Striano, P.; Cangemi, G.; Pacifici, R.; Pichini, S.; Busardo, F. P. |